NIH-funded research R03 grant

Nanobody tools to study NEIL1 and NEIL2 in DNA repair

Official title: Innovative Nanobody Tools for NEIL1 and NEIL2: Overcoming Barriers in DNA Repair Research

Funded at University of South Alabama · NIH-11435762 · Data updated 2026-11-12

A small, targeted grant will create special nanobodies to study how NEIL1 and NEIL2 repair damaged DNA in human cells and mitochondria.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of South Alabama
NIH-funded
Lab location1 site (Mobile, United States)
Project startAugust 5, 2026
Project endAugust 4, 2028
Funding year2026
Award (this year)$156,000
NIH project number1R03ES038960-01
Project IDNIH-11435762 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include people with conditions linked to oxidative DNA damage or those interested in participating in future biomarker or mechanism studies tied to DNA repair.

Less likely to help

Healthy individuals or studies not involving human samples or patient data may not directly benefit.

What this research studies

This project will develop single-domain antibodies (nanobodies) that bind NEIL1 and NEIL2 to enable detailed structural and live-cell studies. The work aims to overcome previous barriers like low protein levels and lack of good antibodies, so researchers can observe NEIL1/NEIL2 behavior during DNA damage. It combines antibody development with imaging approaches to visualize how these enzymes respond to oxidative DNA lesions in real time.

Why it matters

Potential benefit: If successful, patients could benefit from faster advances in understanding how DNA repair fails in age-related diseases and cancer, which may inform future therapies.

How similar studies have gone: Earlier work showed that nanobodies can stabilize NEIL1 for imaging, supporting the feasibility of this approach.

Where this research is happening

  • University of South Alabama
    Mobile, United States
    Active

Researchers

  • Principal investigator: Prakash, Aishwarya — University of South Alabama
  • Study coordinator: Prakash, Aishwarya

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.